A Randomized Controlled Trial Assessing the Efficacy of Ayur Nutra Modak Versus Rajah Pravartini Vati in the Management of Artava Kshaya among Reproductive-Age Women

A Comparative Study to Evaluate the Efficacy of Ayur Nutra Modak -A Formulation of Maasha (Black Gram), Tila (Sesame) and Gud (Jaggery) With Rajah Pravartini Vati and Rajah Pravartini Vati alone in Artava Kshaya (Hypomenorrhea) among Reproductive-Age Females: A Randomized Controlled Trial - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100797

Enrollment

Registered

2026-01-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N913- Primary oligomenorrhea

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with Artava Kshaya (Hypomenorrhea) based on classical Ayurvedic lakshanas and modern diagnostic criteria Duration of menstruation equal or less than 2days Flow scanty (uses equal or less than 2 pad per day or less than 20 ml per cycle) Delayed cycles (more than 35 days) in some cases Not taking any hormonal treatment or Ayurvedic medicines for menstruation in the past 1 month. Fourth phenotype of PCOD-Mild or Norm androgenic PCOS, which is defined by oligomenorrhea, PCO, and normal androgens. Under control Thyroid Dysfunction. Patients presenting with the Pratyatma lakshana of Artava Kshaya. Yathochitakala-adarshanam (irregular menses) Atyalpataa (Hypomenorrhoea) scanty menses Yonivedana (Dysmenorrhoea) painful menses

Exclusion criteria

Exclusion criteria: Pregnant or lactating women. History of secondary amenorrhea due to systemic diseases, e.g., PCOS (Except phenotype 4), thyroid (uncontrolled thyroid) dysfunction, hyperprolactinemia, tuberculosis, etc. Known cases of chronic systemic illness. Women on hormonal therapy or oral contraceptive pills in the past 1 month. Any psychiatric illness or severe stress disorder affecting menstrual cycle.

Design outcomes

Primary

Measure	Time frame
Improvement in menstrual flow (duration and volume) assessed by pictorial blood loss assessment chart (PBAC).Timepoint: baseline,4th week,8th week,16th week	—

Secondary

Measure	Time frame
hanges in associated symptoms, endometrial thickness (by USG), CBC, Serum Estradiol etc.Timepoint: baseline,4th week,8th week,16th week	—

Countries

India

Contacts

Public ContactDr Neeraj Kumar Joshi

Ch Brahm Prakash Ayurved Charak Sansthan

neerajjoshi108@gmail.com8800130663

Outcome results